Smart Healthcare for Diabetes: A COVID-19 Perspective
AI-generated Key Points
⚠The license of the paper does not allow us to build upon its content and the key points are generated using the paper metadata rather than the full article.
- Diabetes and COVID-19 have a critical comorbidity
- Diabetic patients are at a higher risk of infection from the novel coronavirus
- 20% to 50% of patients infected with COVID-19 pandemic have diabetes depending on the region in the globe
- The article provides recommendations for controlling diabetes during this pandemic situation
- Case studies of COVID-19 at various regions around the globe and preventive actions taken by various countries are presented
- Smart healthcare solutions for diabetes patients to have glucose insulin control for protection against COVID-19 are offered
- Diabetic patients should take extra precautions during this pandemic including monitoring blood sugar levels regularly, following a healthy diet plan, exercising regularly while adhering to social distancing guidelines and avoiding nonessential travel.
Authors: Amit M. Joshi, Urvashi P. Shukla, Saraju P. Mohanty
Abstract: Diabetes is considered as an critical comorbidity linked with the latest coronavirus disease 2019 (COVID-19) which spreads through Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2). The diabetic patients have higher threat of infection from novel corona virus. Depending on the region in the globe, 20% to 50% of patients infected with COVID-19 pandemic had diabetes. The current article discussed the risk associated with diabetic patients and also recommendation for controlling diabetes during this pandemic situation. The article also discusses the case study of COVID-19 at various regions around the globe and the preventive actions taken by various countries to control the effect from the virus. The article presents several smart healthcare solutions for the diabetes patients to have glucose insulin control for the protection against COVID-19.
Ask questions about this paper to our AI assistant
You can also chat with multiple papers at once here.
⚠The license of the paper does not allow us to build upon its content and the AI assistant only knows about the paper metadata rather than the full article.
Welcome to our AI assistant! Here are some important things to keep in mind:
- The assistant will only answer questions related to this specific paper.
- Please note that this is not a bot for casual chatting.
- If you want the answer in a language other than the language you chose for navigating the website, simply add "TRANSLATE IN LANGUAGE L" at the end of your query (replace "LANGUAGE L" with the language of your choice).
- For example, you could ask "Can you extract the most important aspect of the paper? TRANSLATE IN SPANISH".
- If you want to keep the history of your questions/answers you should create an account.
Assess the quality of the AI-generated content by voting
Why do we need votes?
Votes are used to determine whether we need to re-run our summarizing tools. If the count reaches -10, our tools can be restarted.
Similar papers summarized with our AI tools
Navigate through even more similar papers through atree representation
Look for similar papers (in beta version)
By clicking on the button above, our algorithm will scan all papers in our database to find the closest based on the contents of the full papers and not just on metadata. Please note that it only works for papers that we have generated summaries for and you can rerun it from time to time to get a more accurate result while our database grows.
Disclaimer: The AI-based summarization tool and virtual assistant provided on this website may not always provide accurate and complete summaries or responses. We encourage you to carefully review and evaluate the generated content to ensure its quality and relevance to your needs.